Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)

Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)

Bibliographic Details
Main Authors: Kuemmerle-Deschner, Jasmin B, Ramos, Eduardo, Blank, Norbert, Roesler, Joachim, Felix, Sandra D, Jung, Thomas, Stricker, Kirstin, Chakraborty, Abhijit, Tannenbaum, Stacey, Wright, Andrew M, Rordorf, Christiane
Format: Online
Language:English
Published: BioMed Central 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241378/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241378/

Similar Items